Abstract
Background Healthcare professionals (HCPs) on the front lines against COVID-19 may face increased workload, and stress. Understanding HCPs’ risk for burnout is critical to supporting HCPs and maintaining the quality of healthcare during the pandemic.
Methods To assess exposure, perceptions, workload, and possible burnout of HCPs during the COVID-19 pandemic we conducted a cross-sectional survey. The main outcomes and measures were HCPs’ self-assessment of burnout and other experiences and attitudes associated with working during the COVID-19 pandemic.
Findings A total of 2,707 HCPs from 60 countries participated in this study. Fifty-one percent of HCPs reported burnout. Burnout was associated with work impacting household activities (RR=1·57, 95% CI=1·39-1·78, P<0·001), feeling pushed beyond training (RR=1·32, 95% CI=1·20-1·47, P<0·001), exposure to COVID-19 patients (RR=1·18, 95% CI=1·05-1·32, P=0·005), making life prioritizing decisions (RR=1·16, 95% CI=1·02-1·31, P=0·03). Adequate personal protective equipment (PPE) was protective against burnout (RR=0·88, 95% CI=0·79-0·97, P=0·01). Burnout was higher in high-income countries (HICs) compared to low- and middle-income countries (LMICs) (RR=1·18; 95% CI=1·02-1·36, P=0·018).
Interpretation Burnout is prevalent at higher than previously reported rates among HCPs working during the COVID-19 pandemic and is related to high workload, job stress, and time pressure, and limited organizational support. Current and future burnout among HCPs could be mitigated by actions from healthcare institutions and other governmental and non-governmental stakeholders aimed at potentially modifiable factors, including providing additional training, organizational support, support for family, PPE, and mental health resources.
Funding N/A
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for the completion of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made available after peer-review publication
